SCHEMBL25820314

SCHEMBL25820314

CC(C)c1ccnc(CS(=O)(=O)C(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ PIK3CA P42336 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ BACE1 P56817 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ HPGD P15428 1/20 0.32
▸ RXRA P19793 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ ALPL P05186 1/20 0.32
▸ JAK2 O60674 2/20 0.31
▸ AURKA O14965 1/20 0.31
▸ DAPK3 O43293 1/20 0.31
▸ MAP4K4 O95819 1/20 0.31
▸ PAK4 O96013 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ LCK P06239 1/20 0.31
▸ FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25825559 0.75 CHRNA7 (0.36) CHRNA7ALDH1A1PIK3CAMTORNPC1
SCHEMBL11994370 0.74 CYP1A2 (0.46) CHRNA7ALDH1A1BACE1KMT2ARXRA
SCHEMBL18542888 0.73 RXRA (0.35) CHRNA7ALDH1A1BACE1RXRAGRIN1
SCHEMBL21705891 0.73 RXRA (0.35) CHRNA7ALDH1A1BACE1RXRAGRIN1
SCHEMBL3507581 0.73 TLR9 (0.38) CHRNA7ALDH1A1BACE1SMN1; SMN2RXRA
SCHEMBL5108681 0.73 JAK2 (0.46) CHRNA7ALDH1A1BACE1RXRAGRIN1
SCHEMBL12120617 0.73 RXRA (0.35) CHRNA7ALDH1A1BACE1SMN1; SMN2RXRA
SCHEMBL16175812 0.72 TYR (0.40) CHRNA7ALDH1A1BACE1KMT2ASMN1; SMN2
SCHEMBL6637270 0.72 ALDH1A1 (0.37) CHRNA7ALDH1A1BACE1KMT2ASMN1; SMN2
SCHEMBL13533992 0.72 KDM4E (0.50) ALDH1A1RXRAGRIN1GRIN2BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA CHRNA7 4364/4885ALDH1A1 3871/4885PIK3CA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback